Chenguang Biotech (300138.SZ) announced results for the first three quarters, with net profit of 62.6059 million yuan, a decrease of 84.28%

Zhitongcaijing · 10/25 12:09

According to the Zhitong Finance App, Chenguang Biotech (300138.SZ) released its report for the third quarter of 2024. The company's revenue for the first three quarters was 5.225 billion yuan, an increase of 1.08% over the previous year. Net profit attributable to shareholders of listed companies was 62.6059 million yuan, a year-on-year decrease of 84.28%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 145.527 million yuan, a year-on-year decrease of 95.53%. Basic earnings per share were $0.12.